- Nineteen prisoners use cutlery to break out of cells at Winchester prison
- France wants progress in Ukraine before Russia returns to G7
- Italy president begins talks to seek way out of government crisis
- Italian PM expected to resign as political chaos deepens
- Russia says US cruise missile test ‘regrettable’
- Kremlin - No date set for Normandy talks on Ukraine despite Macron meeting
- Egypt court hands out 6 death sentences on terror charges
- Putin says Russian nuclear explosion poses no threat
- Russian panel eyes alleged foreign interference in protests
- Gran Canaria wildfire triggers evacuation of thousands of people
- PM Johnson calls on Germany and France to compromise on Brexit
- Sudan's ex-president Bashir arrives at corruption trial
Saturday, 06 February 2021 (YJC)_EU High Representative for International Affairs and Security Policy Josep Borrel expressed hope for the registration of the drug in Europe.
"I took the floor to congratulate Russia on the successful completion of trials of the vaccine against COVID-19. The drug will benefit all of humanity, since we will have more tools to combat the pandemic," said Josep Borrel during a visit to Moscow.
The head of EU diplomacy also recalled the publication of information about Sputnik V in the Lancet magazine. "I hope that the European Medicines Agency will be able to certify the Russian vaccine for use in the EU countries," added Josep Borrel.
The journal the Lancet reported that Sputnik V has an efficacy of 91.6%. The World Health Organization confirmed the effectiveness of the Russian vaccine against COVID-19.
Experts from Stanford and Harvard Universities also appreciated the Russian drug.
Your Comment